These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

421 related articles for article (PubMed ID: 34885693)

  • 1. The Multifaceted Role of Curcumin in Advanced Nanocurcumin Form in the Treatment and Management of Chronic Disorders.
    Tagde P; Tagde P; Islam F; Tagde S; Shah M; Hussain ZD; Rahman MH; Najda A; Alanazi IS; Germoush MO; Mohamed HRH; Algandaby MM; Nasrullah MZ; Kot N; Abdel-Daim MM
    Molecules; 2021 Nov; 26(23):. PubMed ID: 34885693
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Curcumin as potential therapeutic natural product: a nanobiotechnological perspective.
    Shome S; Talukdar AD; Choudhury MD; Bhattacharya MK; Upadhyaya H
    J Pharm Pharmacol; 2016 Dec; 68(12):1481-1500. PubMed ID: 27747859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent advances in curcumin-based nanoformulations in diabetes.
    Ataei M; Gumpricht E; Kesharwani P; Jamialahmadi T; Sahebkar A
    J Drug Target; 2023 Aug; 31(7):671-684. PubMed ID: 37354074
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanotechnology-applied curcumin for different diseases therapy.
    Ghalandarlaki N; Alizadeh AM; Ashkani-Esfahani S
    Biomed Res Int; 2014; 2014():394264. PubMed ID: 24995293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced anti-cancer and antimicrobial activities of curcumin nanoparticles.
    Adahoun MA; Al-Akhras MH; Jaafar MS; Bououdina M
    Artif Cells Nanomed Biotechnol; 2017 Feb; 45(1):98-107. PubMed ID: 26747522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanocurcumin: a promising therapeutic advancement over native curcumin.
    Flora G; Gupta D; Tiwari A
    Crit Rev Ther Drug Carrier Syst; 2013; 30(4):331-68. PubMed ID: 23662605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conjugation of micro/nanocurcumin particles to ZnO nanoparticles changes the surface charge and hydrodynamic size thereby enhancing its antibacterial activity against Escherichia coli and Staphylococcus aureus.
    Shome S; Talukdar AD; Tewari S; Choudhury S; Bhattacharya MK; Upadhyaya H
    Biotechnol Appl Biochem; 2021 Jun; 68(3):603-615. PubMed ID: 32533898
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Curcumin nanoparticles: preparation, characterization, and antimicrobial study.
    Bhawana ; Basniwal RK; Buttar HS; Jain VK; Jain N
    J Agric Food Chem; 2011 Mar; 59(5):2056-61. PubMed ID: 21322563
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential amelioration of nicotine-induced toxicity by nanocurcumin.
    Chattopadhyay K; Samanta A; Mukhopadhyay S; Chattopadhyay B
    Drug Dev Res; 2018 May; 79(3):119-128. PubMed ID: 29573360
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic Applications of Curcumin in Diabetes: A Review and Perspective.
    Quispe C; Herrera-Bravo J; Javed Z; Khan K; Raza S; Gulsunoglu-Konuskan Z; Daştan SD; Sytar O; Martorell M; Sharifi-Rad J; Calina D
    Biomed Res Int; 2022; 2022():1375892. PubMed ID: 35155670
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Curcumin-Based Nanoformulations: A Promising Adjuvant towards Cancer Treatment.
    Hafez Ghoran S; Calcaterra A; Abbasi M; Taktaz F; Nieselt K; Babaei E
    Molecules; 2022 Aug; 27(16):. PubMed ID: 36014474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel dipeptide nanoparticles for effective curcumin delivery.
    Alam S; Panda JJ; Chauhan VS
    Int J Nanomedicine; 2012; 7():4207-22. PubMed ID: 22915849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Curcumin as a therapeutic agent in leukemia.
    Kouhpeikar H; Butler AE; Bamian F; Barreto GE; Majeed M; Sahebkar A
    J Cell Physiol; 2019 Aug; 234(8):12404-12414. PubMed ID: 30609023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent advances in curcumin nanoformulation for cancer therapy.
    Lee WH; Loo CY; Young PM; Traini D; Mason RS; Rohanizadeh R
    Expert Opin Drug Deliv; 2014 Aug; 11(8):1183-201. PubMed ID: 24857605
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of Nanocurcumin as an Add-On Treatment for Patients Hospitalized with COVID-19: A Double-Blind, Randomized Clinical Trial.
    Ahmadi S; Mehrabi Z; Zare M; Ghadir S; Masoumi SJ
    Int J Clin Pract; 2023; 2023():5734675. PubMed ID: 37547100
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic Applications of Curcumin Nanoformulations.
    Yallapu MM; Nagesh PK; Jaggi M; Chauhan SC
    AAPS J; 2015 Nov; 17(6):1341-56. PubMed ID: 26335307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transformation of curcumin from food additive to multifunctional medicine: nanotechnology bridging the gap.
    Ahmad MZ; Akhter S; Mohsin N; Abdel-Wahab BA; Ahmad J; Warsi MH; Rahman M; Mallick N; Ahmad FJ
    Curr Drug Discov Technol; 2014; 11(3):197-213. PubMed ID: 24934264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Purely aqueous PLGA nanoparticulate formulations of curcumin exhibit enhanced anticancer activity with dependence on the combination of the carrier.
    Nair KL; Thulasidasan AK; Deepa G; Anto RJ; Kumar GS
    Int J Pharm; 2012 Apr; 425(1-2):44-52. PubMed ID: 22266528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Curcumin nanoformulations: a future nanomedicine for cancer.
    Yallapu MM; Jaggi M; Chauhan SC
    Drug Discov Today; 2012 Jan; 17(1-2):71-80. PubMed ID: 21959306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nanocurcumin Inhibits Angiogenesis via Down-regulating hif1a/VEGF-A Signaling in Zebrafish.
    Cao Z; He S; Peng Y; Liao X; Lu H
    Curr Neurovasc Res; 2020; 17(2):147-154. PubMed ID: 32031071
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.